| NCT01599884 | Center for Veterans Research and Education | Chronic Obstructive Pulmonary Disease|Chronic Bronchitis | 2012-06 | NA |
| NCT07414212 | Biogipuzkoa Health Research Institute | Amyotrophic Lateral Sclerosis | 2025-11-25 | PHASE1|PHASE2 |
| NCT03400709 | Hospital San Juan de Dios, Santiago | Cisplatin Adverse Reaction|Hearing Loss Ototoxic | 2015-11 | NA |
| NCT07470242 | Pusan National University Hospital | Chronic Rhinosinusitis | 2021-10-13 | NA |
| NCT03306979 | Sunnybrook Health Sciences Centre | Vascular Cognitive Impairment no Dementia | 2018-04-30 | PHASE2 |
| NCT04945096 | The First Affiliated Hospital of Soochow University | Engraft Failure|Relapse|GVHD | 2021-07-01 | PHASE3 |
| NCT02569957 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|National Institutes of Health (NIH) | Malignant Ovarian Endometrioid Tumor|Malignant Ovarian Serous Tumor|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma | 2015-10-02 | PHASE2 |
| NCT04918719 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Acute Ischemic Stroke | 2023-11-02 | PHASE2 |
| NCT06039280 | Institute of Liver and Biliary Sciences, India | Hepatocellular Carcinoma | 2023-09-15 | NA |
| NCT02688361 | GlaxoSmithKline | Infections, Respiratory Tract | 2016-02-22 | PHASE1 |
| NCT02123511 | Mayo Clinic|National Cancer Institute (NCI) | Mucositis|Oral Complications|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage I Adenoid Cystic Carcinoma of the Oral Cavity|Stage I Basal Cell Carcinoma of the Lip|Stage I Lymphoepithelioma of the Nasopharynx|Stage I Lymphoepithelioma of the Oropharynx|Stage I Mucoepidermoid Carcinoma of the Oral Cavity|Stage I Salivary Gland Cancer|Stage I Squamous Cell Carcinoma of the Larynx|Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage I Squamous Cell Carcinoma of the Nasopharynx|Stage I Squamous Cell Carcinoma of the Oropharynx|Stage I Verrucous Carcinoma of the Larynx|Stage I Verrucous Carcinoma of the Oral Cavity|Stage II Adenoid Cystic Carcinoma of the Oral Cavity|Stage II Basal Cell Carcinoma of the Lip|Stage II Lymphoepithelioma of the Nasopharynx|Stage II Lymphoepithelioma of the Oropharynx|Stage II Mucoepidermoid Carcinoma of the Oral Cavity|Stage II Salivary Gland Cancer|Stage II Squamous Cell Carcinoma of the Larynx|Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage II Squamous Cell Carcinoma of the Nasopharynx|Stage II Squamous Cell Carcinoma of the Oropharynx|Stage II Verrucous Carcinoma of the Larynx|Stage II Verrucous Carcinoma of the Oral Cavity|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Basal Cell Carcinoma of the Lip|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Lymphoepithelioma of the Oropharynx|Stage III Mucoepidermoid Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVA Basal Cell Carcinoma of the Lip|Stage IVA Lymphoepithelioma of the Oropharynx|Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVA Salivary Gland Cancer|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVB Basal Cell Carcinoma of the Lip|Stage IVB Lymphoepithelioma of the Oropharynx|Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVB Salivary Gland Cancer|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVC Basal Cell Carcinoma of the Lip|Stage IVC Lymphoepithelioma of the Oropharynx|Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVC Salivary Gland Cancer|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Oropharynx|Stage IVC Verrucous Carcinoma of the Larynx|Stage IVC Verrucous Carcinoma of the Oral Cavity|Tongue Cancer | 2014-04 | PHASE2 |
| NCT05804123 | Anabio R&D|Thai Binh University of Medicine and Pharmacy | Upper Respiratory Tract Infections | 2021-10-28 | NA |
| NCT00736866 | Hospital do Coracao|Medley Pharmaceutical Industry SA | Acute Kidney Failure | 2008-08 | PHASE3 |
| NCT00558142 | University of Edinburgh|NHS Lothian | Radiocontrast-induced Nephropathy | 2008-02 | PHASE4 |
| NCT01050270 | University of Edinburgh|NHS Lothian|Chief Scientist Office of the Scottish Government | Overdose | 2010-09 | PHASE4 |
| NCT06122311 | Helwan University | Drug-Induced Nephropathy | 2023-08-25 | NA |
| NCT02080182 | Shahid Beheshti University of Medical Sciences | Pyelonephritis | 2014-01 | PHASE2 |
| NCT04368598 | Peking University People´s Hospital | Immune Thrombocytopenia | 2019-04-01 | PHASE2 |
| NCT01160627 | Odense University Hospital | Contrast Induced Nephropathy | 2010-04 | NA |
| NCT00569465 | University of Turin, Italy | Type 2 Diabetes Mellitus|Hypertension | 2005-01 | PHASE4 |
| NCT02882477 | Hadassah Medical Organization | Diabetes Mellitus|Iron Metabolism Disorders|Gastroduodenal Ulcer|Optic Atrophy|Sensorineural Hearing Loss|Platelet Dysfunction | 2016-12 | PHASE2|PHASE3 |
| NCT03177395 | Egetis Therapeutics|University of Edinburgh|NHS Lothian | Paracetamol Overdose | 2017-06-08 | PHASE1 |
| NCT04123405 | Sandoz | Rhinosinusitis | 2020-10-22 | PHASE3 |
| NCT00525551 | Karolinska University Hospital|Karolinska Institutet|AstraZeneca | Otosclerosis | 2007-09 | PHASE4 |
| NCT05258682 | Mucpharm Pty Ltd|St George Hospital, Australia | COVID-19 Pneumonia|COVID-19|Ventilator Associated Pneumonia|COVID-19 Acute Respiratory Distress Syndrome | 2022-05-01 | PHASE1|PHASE2 |
| NCT00564642 | National Research Institute of Tuberculosis and Lung Disease, Iran | Hepatitis|Tuberculosis | 2007-11 | NA |
| NCT00492518 | Technical University of Munich | Contrast Induced Nephropathy|Kidney Diseases|Renal Failure|Adverse Effects | 2002-02 | PHASE4 |
| NCT01223326 | Clinica Universidad de Navarra, Universidad de Navarra | Hepatectomy|Reperfusion Injury | 2003-01 | PHASE4 |
| NCT00568113 | Assiut University | Preterm Labour | 2007-07 | PHASE4 |
| NCT02357303 | Portuguese Oncology Institute, Coimbra | Gastric Mucosal Lesion | 2015-04 | PHASE4 |
| NCT05070650 | Sandoz | Common Cold | 2024-09-20 | PHASE3 |
| NCT01564303 | The Nazareth Hospital|Western Galilee Hospital-Nahariya | Contrast Media Induced Nephropathy | 2012-05 | NA |
| NCT02723669 | Arbor Pharmaceuticals, Inc. | Healthy | 2014-04 | PHASE1 |
| NCT00996424 | University Hospital, Ghent|BVSM | Cystic Fibrosis | 2010-01 | PHASE4 |
| NCT02760901 | Ain Shams University | Cisplatin Nephrotoxicity | 2013-11 | PHASE2 |
| NCT00399256 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Chronic Kidney Failure | 2004-03 | NA |
| NCT02818270 | Chang Gung University|Chang Gung Memorial Hospital | Chronic Obstructive Pulmonary Disease | 2016-06 | NA |
| NCT02168387 | Duke University | Atelectasis | 2010-12 | PHASE4 |
| NCT02788292 | Nova Scotia Health Authority | Adipose Tissue Atrophy|Deformity of Reconstructed Breast|Graft Loss | 2016-08-15 | PHASE4 |
| NCT03976973 | Mucpharm Pty Ltd|Mercy Medical Center|Wake Forest University Health Sciences|University of Pittsburgh Medical Center|Catharina Ziekenhuis Eindhoven|Hospital Universitario Reina Sofia de Cordoba | Pseudomyxoma Peritonei|Peritoneal Cancer|Mucinous Adenocarcinoma|Mucinous Tumor | 2022-05 | PHASE2 |
| NCT05911282 | University Medical Centre Ljubljana | Ethanol Intoxication | 2021-06-01 | NA |
| NCT00003346 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Melanoma (Skin) | 1997-11 | PHASE2 |
| NCT02476526 | VA Greater Los Angeles Healthcare System|General Electric | Chronic Kidney Disease|Pulmonary Embolism|Renal Artery Stenosis|Pulmonary Cancer | 2008-09 | PHASE4 |
| NCT04531163 | Al-Azhar University | Diabetic Kidney Disease|Diabetes Mellitus, Type 2|Diabetic Nephropathies | 2019-10-01 | PHASE2|PHASE3 |
| NCT01015209 | Medical University of Vienna | Dry Eye Syndromes | 2010-09 | PHASE1 |
| NCT05539053 | Department of Medical Services Ministry of Public Health of Thailand | Chemotherapy-induced Peripheral Neuropathy | 2022-11-01 | NA |
| NCT00247507 | Far Eastern Memorial Hospital | Anemia|Atherosclerosis|End-Stage Renal Disease|Oxidative Stress|Pro-Inflammation | 2005-09 | PHASE4 |
| NCT00396396 | Eastern Virginia Medical School | Creatinine Clearance | 2006-10 | NA |
| NCT01753752 | Gerhard Garhofer|Croma-Pharma GmbH | Dry Eye Syndrome | 2012-09 | PHASE2 |
| NCT02159196 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development | Respiratory Failure | 2014-07 | NA |
| NCT00353340 | Shaare Zedek Medical Center | Acute Renal Failure Contrast Nephropathy | 2005-01 | NA |
| NCT03460808 | Peking University People´s Hospital | Immune Thrombocytopenia | 2018-03-10 | PHASE1|PHASE2 |
| NCT01381354 | University of Iowa|Direct MS Canada|DJO Incorporated|Pinnaclife Inc.|TZ Press, LLC | Multiple Sclerosis | 2010-10 | PHASE1 |
| NCT00187330 | Sunnybrook Health Sciences Centre|The Physicians´ Services Incorporated Foundation | Heart Disease|Renal Insufficiency | 2004-03 | PHASE2 |
| NCT03707951 | Medical University of South Carolina | Alcohol Use Disorder | 2019-02-27 | PHASE2 |
| NCT01849016 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Erasmus Medical Center|Haga Hospital|University Medical Center Groningen|ZonMw: The Netherlands Organisation for Health Research and Development|Fonds NutsOhra|Stichting Janivo|CHU Brugmann, Brussels|Erasme University Hospital|Centre Hospitalier Régional de la Citadelle|University Hospital St Luc, Brussels|Centre Hospitalier Universitaire Saint Pierre|Queen Fabiola Children´s University Hospital|Guy´s and St Thomas´ NHS Foundation Trust | Sickle Cell Disease | 2013-04 | PHASE3 |
| NCT04792021 | Ain Shams University|Misr International University | Corona Virus Disease 19 (Covid19)|Corona Virus Infection|Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2) | 2021-03-09 | PHASE3 |
| NCT02269540 | Centre for Addiction and Mental Health | Major Depressive Disorder | 2014-10 | EARLY_PHASE1 |
| NCT00736541 | Ibtesam Hilmi | End Stage Liver Failure | 2004-07 | NA |
| NCT00552786 | National Taiwan University Hospital|Institute of Occupational Safety and Health, Taiwan|Municipal Hospital of Tainan, Taiwan | Hearing Loss | 2007-11 | PHASE2 |
| NCT03121222 | Aristotle University Of Thessaloniki|National and Kapodistrian University of Athens|European University Cyprus | Glutathione Metabolism Anemias | 2015-11-01 | PHASE2 |
| NCT02212678 | University of Minnesota|Parkinson´s Disease Society of the United Kingdom | Parkinson Disease | 2014-09 | PHASE2 |
| NCT02579772 | Queen´s University | Pulmonary Disease, Chronic Obstructive | 2015-07 | PHASE4 |
| NCT00614757 | Midwest Biomedical Research Foundation | Insulin Resistance|Metabolic Syndrome x | 2005-05 | NA |
| NCT01587001 | National Jewish Health|American Thoracic Society | Pulmonary Sarcoidosis | 2011-11 | NA |
| NCT02088502 | Isfahan University of Medical Sciences | Contrast-Induced Nephropathy | 2013-09 | PHASE2|PHASE3 |
| NCT02505477 | University of California, Los Angeles | Schizophrenia|Cognitive Deficits|Schizophrenia; Negative Type | 2017-02-06 | PHASE4 |
| NCT01993849 | Kevin Gray, MD | Onychophagia | 2013-10 | PHASE3 |
| NCT01187108 | University of Colorado, Denver|Universidad Peruana Cayetano Heredia|Jackson, Brian, M.S.|Thomas H Maren Foundation | Erythrocytosis|Mountain Sickness | 2013-06 | PHASE1|PHASE2 |
| NCT01138137 | OHSU Knight Cancer Institute | Ovarian Carcinoma, Stage 3 or 4|Epithelial Ovarian Carcinoma|Primary Peritoneal Carcinoma | 2010-06 | PHASE1 |
| NCT06956157 | Guangdong Provincial People´s Hospital | Obsessive Compulsive Disorder (OCD) | 2022-06-22 | PHASE4 |
| NCT03197103 | Centre of Postgraduate Medical Education | Breast; Deformity, Congenital|Graft Loss|Adipose Tissue Atrophy|Breast; Atrophy | 2017-07-04 | PHASE4 |
| NCT02420418 | Universidade Estadual de Londrina | Bipolar Disorder | 2015-07 | NA |
| NCT07136987 | Open Source Pharma Foundation|National Institute for Research in Tuberculosis, Chennai, India | Tuberculosis | 2026-01 | PHASE3 |
| NCT02335060 | Yale University | Healthy | 2014-05-02 | EARLY_PHASE1 |
| NCT00004467 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Texas Southwestern Medical Center | Acute Liver Failure | 1998-06 | PHASE3 |
| NCT01467466 | VA Office of Research and Development|The George Institute | Acute Renal Failure|Kidney Disease|Coronary Artery Disease | 2013-10-07 | PHASE3 |
| NCT00374088 | University of Michigan | Transposition of Great Vessels|Congenital Heart Disease | 2005-02 | PHASE2 |
| NCT05081479 | Memorial Sloan Kettering Cancer Center | Lymphoma | 2021-12-08 | PHASE1 |
| NCT00650091 | Duke University|National Heart, Lung, and Blood Institute (NHLBI) | Pulmonary Fibrosis | 2009-10 | PHASE3 |
| NCT01470027 | Weill Medical College of Cornell University|National Institute on Aging (NIA) | Parkinson Disease | 2012-01 | PHASE1|PHASE2 |
| NCT05604586 | Poznan University of Life Sciences | Skeletal Muscle Performance|Gene Polymorphisms | 2022-05-01 | NA |
| NCT06727422 | Mark Pimentel, MD | IBS (Irritable Bowel Syndrome)|IBS-D (Diarrhea-predominant) | 2026-02-04 | PHASE2 |
| NCT00556465 | Shiraz University of Medical Sciences | Diabetic Nephropathy|Chronic Kidney Disease|Diabetes Type 2 | 2007-01 | PHASE2|PHASE3 |
| NCT02362425 | National Institute of Nursing Research (NINR) | Neuromuscular Disease | 2015-02-12 | PHASE1|PHASE2 |
| NCT00397735 | Ohio State University | Labor, Premature|Preterm Premature Rupture of the Membranes|Infection|Inflammation|Chorioamnionitis | 2006-10-01 | PHASE1|PHASE2 |
| NCT02357290 | Massachusetts General Hospital | Bipolar Disorder | 2014-01 | PHASE4 |
| NCT02040818 | University of California, San Diego|National Institutes of Health (NIH) | Hemodialysis Catheter-related Bacteremia | 2013-11 | PHASE2|PHASE3 |
| NCT04562597 | Medical University of South Carolina | Surgery | 2021-01-20 | PHASE1|PHASE2 |
| NCT02707640 | Hoffmann-La Roche | Idiopathic Pulmonary Fibrosis | 2013-08 | PHASE2 |
| NCT07093944 | Kurdistan University of Medical Sciences | Parkinson's Disease (PD) | 2018-04-09 | PHASE2 |
| NCT03423667 | Salvatore Campanella | Cocaine Addiction | 2019-03-01 | PHASE2 |
| NCT00724594 | Medical University of South Carolina|National Institute of Neurological Disorders and Stroke (NINDS) | Chorioamnionitis|Brain Injury | 2008-08 | PHASE1|PHASE2 |
| NCT00497328 | National University Hospital, Singapore | Contrast Induced Nephropathy | 2007-08 | PHASE2|PHASE3 |
| NCT06872372 | Lahore General Hospital | Acute Liver Failure|Drug-Induced Liver Injury | 2025-01-15 | NA |
| NCT00332631 | Austin Health | Cardiac Surgery and Cardiopulmonary Bypass | 2004-08 | PHASE2 |
| NCT03492047 | Ain Shams University|Nasser Institute For Research and Treatment | Peripheral Neuropathy Due to Chemotherapy | 2018-04-01 | PHASE1|PHASE2 |
| NCT02737358 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Nicotine Dependence|Smoking | 2016-08-30 | PHASE2 |
| NCT01905696 | Duke University | Focus is Determination of the Role of SNO-Hb in Forearm Blood Flow Regulation | 2013-03 | EARLY_PHASE1 |
| NCT06260566 | Sanjiv Harpavat|Baylor College of Medicine | Biliary Atresia | 2026-10 | PHASE1 |
| NCT01111422 | Ewha Womans University | End-Stage Kidney Disease|Peritoneal Dialysis | 2010-03 | PHASE4 |
| NCT04712435 | Instituto Brasileiro de Controle do Cancer | Sinusoidal Obstruction Syndrome (SOS)|Hematopoietic Stem Cell Transplant (HSCT) | 2021-04 | PHASE2 |
| NCT01359722 | Instituto do Coracao|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Kidney Failure, Acute|Oxidative Stress Induction | 2010-03 | NA |
| NCT02379637 | Novartis | Common Cold Associated With Cough | 2015-01 | PHASE2 |
| NCT01907061 | Baylor Research Institute | Acute Renal Failure | 2007-07 | NA |
| NCT07325383 | Tehran University of Medical Sciences|Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Iran | Oral Mucositis|Hematopoietic Stem Cell Transplantation (HSCT) | 2024-08-18 | PHASE3 |
| NCT00915200 | The University of Texas Health Science Center at San Antonio|National Center for Complementary and Integrative Health (NCCIH)|VA Office of Research and Development | Diabetic Nephropathies|Proteinuria|Oxidative Stress | 2009-10 | PHASE2 |
| NCT03252925 | The First Affiliated Hospital of Soochow University | Thrombotic Microangiopathies|Hematologic Diseases | 2017-11-01 | PHASE3 |
| NCT05241262 | Michio Hirano, MD|United States Department of Defense | Mitochondrial Disease | 2023-07-06 | PHASE1 |
| NCT02294591 | Region Syddanmark | Bipolar Disorder | 2014-11 | PHASE2 |
| NCT01005810 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Cannabis Dependence | 2009-09 | PHASE2 |
| NCT00421785 | Assaf-Harofeh Medical Center | ESRD|Peritoneal Dialysis | 2007-02 | NA |
| NCT01506765 | Centre Hospitalier Universitaire Vaudois | Schizophrenia | 2003-08 | PHASE1 |
| NCT04643821 | Medical University of South Carolina|National Institute for Health Research, United Kingdom|National Institute of Neurological Disorders and Stroke (NINDS)|Carlos III Health Institute | HIE - Perinatal Hypoxic - Ischemic Encephalopathy | 2015-01-01 | EARLY_PHASE1 |
| NCT05294744 | Bioaraba Health Research Institute | Alcoholic Hepatitis | 2022-10-07 | NA |
| NCT02348762 | Baylor College of Medicine | Aging|Erythrocyte Glutathione Deficiency|Muscle Weakness | 2014-11 | PHASE1 |
| NCT01386645 | Seattle Institute for Biomedical and Clinical Research|VA Puget Sound Health Care System | Impaired Glucose Tolerance|Oxidative Stress|Prediabetes|Impaired Fasting Glucose | 2011-07 | NA |
| NCT01394419 | Yonsei University | Postoperative Acute Kidney Injury After Off-pump Coronary Artery Bypass Graft | 2010-09 | PHASE4 |
| NCT05798481 | University of Alabama at Birmingham | Hypertension|Cardiovascular Diseases | 2024-03-27 | EARLY_PHASE1 |
| NCT02124525 | Universidade Estadual de Londrina | Tobacco Smoking|Oxidative Stress|Inflammation | 2013-02 | PHASE3 |
| NCT03757585 | Massachusetts General Hospital|Demarest Lloyd Jr. Foundation | Non-verbal Learning Disorder|Autism Spectrum Disorder|Autism | 2019-05-20 | PHASE4 |
| NCT00969904 | University Hospital, Antwerp | COPD | 2009-03 | PHASE4 |
| NCT01138956 | Hospital Universitário Professor Edgard Santos | Visceral Leishmaniasis|Immune Response|Treatment | 2010-04 | NA |
| NCT03843541 | Zambon SpA | Respiratory Tract Diseases|Abnormal Mucus Secretions | 2019-06-25 | PHASE3 |
| NCT00575419 | Oregon Health and Science University | Contrast Induced Nephropathy | 2007-11 | PHASE1 |
| NCT02994875 | Yale University|National Institute on Drug Abuse (NIDA) | Cocaine Dependence | 2016-05 | EARLY_PHASE1 |
| NCT01111734 | University of Minnesota|Minnesota Medical Foundation | Deliberate Self Harm | 2011-03 | PHASE1 |
| NCT01555970 | University of Sao Paulo|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Obsessive-Compulsive Disorder | 2012-03 | PHASE2 |
| NCT01778309 | Democritus University of Thrace | Skeletal Muscle Damage|Skeletal Muscle Performance|Intgracellular Signaling in Skeletal Muscle|Inflammatory Status | 2010-01 | NA |
| NCT03018236 | Hospital de Clinicas de Porto Alegre|Secretaria Nacional de Políticas sobre Drogas (SENAD) | Cocaine Addiction|Alcohol Addiction | 2017-01 | PHASE4 |
| NCT01232257 | A.C. Abrahams | Chronic Kidney Disease|Chronic Kidney Failure|End Stage Kidney Disease|End Stage Renal Disease | 2011-07 | PHASE3 |
| NCT03881163 | Zambon SpA | Respiratory Tract Disorders | 2019-11-11 | PHASE1 |
| NCT04481035 | Children´s Hospital Medical Center, Cincinnati | Neurofibromatosis 1 | 2019-01-15 | PHASE2 |
| NCT00391911 | Royal Alexandra Hospital|University of Alberta|Gambro Renal Products, Inc. | Rhabdomyolysis | 2006-11 | PHASE2 |
| NCT00188630 | University Health Network, Toronto|Heart and Stroke Foundation of Ontario | Heart Disease|Acute Renal Failure | 2003-07 | PHASE3 |
| NCT04520139 | University of California, Irvine|Jarrow Formulas Inc | Ovarian Cancer|Cognitive Impairment | 2026-05 | PHASE1|PHASE2 |
| NCT06179056 | Zagazig University | Acne Vulgaris | 2023-03-01 | |
| NCT02499029 | Medical University of South Carolina | PTSD|Addiction | 2013-02 | PHASE2 |
| NCT01131572 | Lindner Center of HOPE | NAC | 2010-02 | PHASE2|PHASE3 |
| NCT06890507 | University of Adelaide | Angina Attacks|Non Obstructive Coronary Artery Disease | 2025-06-01 | PHASE2 |
| NCT04864496 | Shahid Beheshti University of Medical Sciences | Retinitis Pigmentosa | 2021-04-17 | PHASE2 |
| NCT04419025 | Cambridge Health Alliance | COVID|Sars-CoV2|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Oxidative Stress | 2020-09-23 | PHASE2 |
| NCT00248625 | University of Pittsburgh|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Acute Liver Failure|Hepatic Encephalopathy | 2000-01 | PHASE3 |
| NCT02930031 | National and Kapodistrian University of Athens | Skeletal Muscle Damage|Aseptic Inflammation|Skeletal Muscle Function | 2015-01 | NA |
| NCT01082445 | University of Turin, Italy | Foot Ulcer, Diabetic | 2009-08 | PHASE3 |
| NCT07567274 | Leading Edge Clinic|Rebuild Medicine | Chronic Subjective Tinnitus | 2026-05-18 | PHASE2 |
| NCT00611897 | Yale University | Cognitive Dysfunction | 2006-01 | PHASE1|PHASE2 |
| NCT01172288 | Yale University|American Academy of Child Adolescent Psychiatry. | Tourettes Syndrome|Tic | 2010-07 | PHASE2 |
| NCT05517668 | Richard Dart, MD, PhD|Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | Acetaminophen|Drug Overdose|Acetaminophen Overdose|Acetaminophen Poisoning|Drug-induced Liver Injury|Liver Failure|Liver Toxicity | 2022-09-12 | PHASE2 |
| NCT00542750 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA)|American Academy of Child Adolescent Psychiatry. | Cannabis Dependence | 2008-01 | PHASE1|PHASE2 |
| NCT02911285 | Medical University of South Carolina|United States Department of Defense|Institute for Translational Neuroscience | Posttraumatic Stress Disorder (PTSD)|Alcohol Use Disorder (AUD)|Substance Use Disorder (SUD) | 2016-10 | PHASE2 |
| NCT00962442 | Erasme University Hospital | Alcoholic Hepatitis | 2000-09 | PHASE3 |
| NCT00851708 | University of Sao Paulo|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Deceased Kidney Transplantation | | NA |
| NCT06236165 | Tanta University | Hepatic and Post Hepatic Jaundice | 2024-02-14 | PHASE2 |
| NCT01037465 | Boston University | Cardiovascular Disease | 2008-09 | NA |
| NCT01384591 | The University of Texas Medical Branch, Galveston|Lantheus Medical Imaging | Aging | 2011-07 | PHASE1|PHASE2 |
| NCT00184977 | Radboud University Medical Center|Dutch Health Care Insurance Board (CVZ)|GlaxoSmithKline|Zambon SpA|The Netherlands Asthma Foundation | Pulmonary Disease, Chronic Obstructive|Lung Diseases, Obstructive|Bronchitis, Chronic | 1998-12 | PHASE4 |
| NCT02719392 | Massachusetts General Hospital | Bipolar Disorder|Bipolar Depression | 2017-08-09 | PHASE4 |
| NCT04523675 | University of Thessaly | Skeletal Muscle Damage|Exercise-induced Aseptic Inflammation|Skeletal Muscle Performance|Antioxidant Status | 2016-04 | NA |
| NCT00211653 | Minneapolis Veterans Affairs Medical Center | Kidney Failure | 2003-04 | PHASE1|PHASE2 |
| NCT05611086 | Teny Tjitra Sari | Lymphoblastic Leukemia, Acute, Childhood | 2019-08-29 | PHASE4 |
| NCT02791945 | University of California, San Francisco|United States Department of Defense|Northern California Institute of Research and Education|San Francisco Veterans Affairs Medical Center|Institute for Translational Neuroscience | Traumatic Brain Injury (TBI)|Hazardous and Harmful Alcohol Use | 2016-08 | PHASE2 |
| NCT01495260 | Pujol, Aurora, M.D.|Ministerio de Sanidad, Servicios Sociales e Igualdad|Fundacion Hesperia | Adrenomyeloneuropathy | 2011-09 | PHASE2 |
| NCT01188005 | University of Athens | Obstructive Sleep Apnea Syndrome | 2010-08 | NA |
| NCT05908513 | University of Missouri-Columbia|Shandong Provincial Hospital|Central South University | Atherosclerosis of Artery|Peripheral Artery Disease|Diabetes Mellitus|Inflammation|Oxidative Stress | 2021-10-15 | PHASE1 |
| NCT04904952 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | OCD | 2020-03-13 | NA |
| NCT01704482 | Assiut University | Cardiac Surgery for Rheumatic Valvular Heart Disease|Renal Dysfunction | 2011-02 | PHASE2 |
| NCT00592618 | Assaf-Harofeh Medical Center | ESRD|Sleep Apnea | | NA |
| NCT02505087 | Assistance Publique - H?pitaux de Paris | Selenoprotein N-related Myopathy | 2015-09 | PHASE2|PHASE3 |
| NCT04764643 | Xijing Hospital of Digestive Diseases | Esophageal Squamous Cell Carcinoma | 2020-02-01 | NA |
| NCT01354132 | Beth Israel Deaconess Medical Center|Center de Neurosciences Psychiatrique, Lausanne, Switzerland | Schizophrenic Psychoses | 2011-05 | PHASE2 |
| NCT00203099 | Teva Branded Pharmaceutical Products R&D, Inc. | Relapse Remitting Multiple Sclerosis | 2004-12 | PHASE2 |
| NCT07082621 | Hams Hamed Abdelrahman | Oral Mucositis | 2024-01-15 | NA |
| NCT00539513 | Yale University | Obsessive-Compulsive Disorder | 2006-06 | PHASE2 |
| NCT00428883 | Università Politecnica delle Marche | Scleroderma, Diffuse | 2007-01 | PHASE2|PHASE3 |
| NCT00512265 | University Hospital, Basel, Switzerland|Triemli Hospital | Pulmonary Morbidity | 2006-01 | PHASE4 |
| NCT05610072 | William Stoops|National Institute on Drug Abuse (NIDA) | Cocaine Use Disorder|Opioid Use Disorder|Stimulant Use Disorder | 2022-12-15 | EARLY_PHASE1 |
| NCT07156786 | Fakultas Kedokteran Universitas Indonesia | Kidney Function Issue|Acute Kidney Injury|Cancer (Solid Tumors)|Kidney Function Tests|Acetylcysteine Adverse Reaction | 2025-09-15 | PHASE2|PHASE3 |
| NCT01885338 | VA Greater Los Angeles Healthcare System|VISN 22 Mental Illness Research, Education, and Clinical Center|American Psychiatric Foundation | Schizophrenia | 2013-06 | PHASE1 |
| NCT01424033 | University of Michigan | Interstitial Lung Disease|Connective Tissue Disease | 2011-12 | PHASE2|PHASE3 |
| NCT01251029 | Assaf-Harofeh Medical Center | Chronic Kidney Diseases|General Anesthesia | 2011-01 | PHASE1 |
| NCT00188773 | University Health Network, Toronto | Insulin Resistance Syndrome X|Pancreatic Beta Cell Function | 2004-01 | PHASE4 |
| NCT00809094 | Stanford University|Cystic Fibrosis Foundation | Cystic Fibrosis | 2008-11 | PHASE2 |
| NCT01063205 | Baylor College of Medicine|National Institute on Drug Abuse (NIDA) | Methamphetamine Abuse|Methamphetamine Dependence|Substance Abuse | 2010-03 | PHASE1 |
| NCT00483314 | McGill University Health Centre+Research Institute of the McGill University Health Centre|March of Dimes | Homocystinuria | 2007-11 | PHASE2 |
| NCT01664260 | Ewha Womans University | Posttraumatic Stress Disorder | 2012-11-01 | PHASE2 |
| NCT03220776 | Medical University of South Carolina|National Institutes of Health (NIH)|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder|Bipolar Disorder | 2017-08-07 | PHASE2 |
| NCT03104725 | National Institute of Neurological Disorders and Stroke (NINDS) | Parkinson Disease|Cerebrospinal Fluid | 2017-09-25 | PHASE1 |
| NCT02241876 | University of Campinas, Brazil | Head and Neck Neoplasms | 2014-10 | PHASE4 |
| NCT01878695 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Stage 0+1 Breast Cancer|Post Biopsy|Pre-surgery | 2012-07-26 | PHASE1 |
| NCT04015557 | Hospital de Clinicas de Porto Alegre|Funda??o de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | CBS Deficiency | 2022-02-11 | PHASE1|PHASE2 |
| NCT00780962 | Beth Israel Deaconess Medical Center|Cumberland Pharmaceuticals | Radiocontrast Nephropathy | 2007-10-16 | PHASE2 |
| NCT01962961 | Indiana University|BioAdvantex Pharma | HIV|Endothelial Dysfunction|Oxidative Stress | 2013-10 | PHASE1|PHASE2 |
| NCT01537926 | The University of Texas Health Science Center, Houston|National Institutes of Health (NIH) | Hypertrophic Cardiomyopathy | 2012-01 | PHASE1 |
| NCT01271088 | TC Erciyes University | Hearing Loss, Extreme | 2010-06 | PHASE2|PHASE3 |
| NCT00998972 | Institut d´Anesthesiologie des Alpes Maritimes | Brain Death|Chronic Renal Insufficiency | 2006-09 | PHASE3 |
| NCT06039566 | Medical University of South Carolina | Hysterectomy | 2023-11-30 | PHASE3 |
| NCT00751257 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Nicotine Dependence | 2006-12 | PHASE2 |
| NCT00463671 | Assaf-Harofeh Medical Center | Diabetic Foot Ulcers | 2003-12 | NA |
| NCT05907486 | The First Affiliated Hospital of Soochow University | Thrombotic Disorder | 2023-08-01 | PHASE3 |
| NCT03679442 | University of Aarhus|The Danish Council for Strategic Research|Novo Nordisk A+S|Savv?rksejer Jeppe Juhl og Hustru Ovita Juhls mindelegat | Drug-Induced Acute Liver Injury | 2014-09-08 | PHASE1 |
| NCT00218491 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Cocaine Dependence | 2005-11 | PHASE2 |
| NCT01726465 | Istituto Clinico Humanitas | Ischemic Reperfusion Injury|Insufficiency; Hepatic, Postoperative|Liver Tumour | 2012-11 | PHASE2 |
| NCT06956482 | University Hospital, Lille | Alcoholic Hepatitis | 2026-02 | PHASE3 |
| NCT00637624 | Rijnstate Hospital | Carcinoma, Non-Small-Cell Lung|Carcinoma, Small Cell Lung|Mesothelioma | 2008-03 | NA |
| NCT00190034 | Far Eastern Memorial Hospital|Synmosa Biopharma Corp. | Cardiovascular Disease|Renal Insufficiency, Acute|Cardiopulmonary Bypass | 2005-01 | PHASE4 |
| NCT00237614 | University of Milan | Contrast-Induced Nephropathy|Acute Myocardial Infarction | 2003-02 | PHASE2|PHASE3 |
| NCT03493178 | Baylor College of Medicine|The Methodist Hospital Research Institute | Mild Cognitive Impairment | 2018-04-19 | EARLY_PHASE1 |
| NCT01210456 | Tokushukai Medical Group | Chronic Kidney Disease | 2009-10 | PHASE3 |
| NCT00716001 | Osaka General Medical Center | Chronic Renal Failure | 2008-07 | PHASE4 |
| NCT07279610 | The First Affiliated Hospital of Soochow University | Thrombotic Microangiopathy | 2024-05-01 | PHASE2|PHASE3 |
| NCT00440869 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | End-Stage Renal Disease|Dialysis|Hemodialysis | 2007-03 | PHASE1 |
| NCT05551624 | Hospital Civil de Guadalajara | Primary Immune Thrombocytopenia | 2018-07-04 | EARLY_PHASE1 |
| NCT02483130 | King´s College London | Psychosis | 2015-06 | |
| NCT06546475 | National Taiwan University Hospital | Psychosis | 2024-08-01 | PHASE4 |
| NCT04703036 | Baylor College of Medicine | Covid19 | 2021-01-11 | EARLY_PHASE1 |
| NCT04928495 | Universidade Federal do Ceara|Paulista School of Medicine-EPM, UNIFESP|Health Surveillance Secretariat - SVS|Central Laboratory of Public Health of Ceara - LACEN-CE|Leonardo da Vinci Hospital - HLV|S?o José Hospital for Infectious Diseases - HSJ|Ceará Health Secretariat - SESA|Municipal Health Secretary - SMS-Fortaleza | COVID-19 | 2021-07-15 | PHASE3 |
| NCT03238300 | Medical University of South Carolina|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Drinking|Control | 2017-10-16 | PHASE2 |
| NCT03636932 | Assistance Publique Hopitaux De Marseille | Chronic Kidney Diseases | 2019-04-30 | PHASE2 |
| NCT01355198 | Baylor College of Medicine | HIV Infection|Erythrocyte Glutathione Deficiency | 2010-08 | PHASE1 |
| NCT00532688 | Bayside Health|The Alfred | Heart Failure, Congestive|Kidney Failure, Chronic | 2007-09 | PHASE2|PHASE3 |
| NCT02206178 | University Hospital, Clermont-Ferrand | Healthy | 2013-09 | PHASE1 |
| NCT07080190 | South Valley University | Urine Alkalinization|N-Acetylcysteine|Hair Dye|Paraphenylene Diamine|Intoxication | 2022-07-01 | NA |
| NCT01739790 | University of Minnesota | COPD|Chronic Bronchitis | 2013-01 | NA |
| NCT05807204 | Fundació Eurecat|Centre de Diagnosi per la Imatge|Laboratorio de Referencia Sud|Centro OWLiver | Visceral Obesity|Non-Alcoholic Fatty Liver Disease | 2023-05-01 | NA |
| NCT01265563 | VA Office of Research and Development|National Center for Complementary and Integrative Health (NCCIH) | Diabetic Nephropathy|Proteinuria|Oxidative Stress | 2011-01 | PHASE2 |
| NCT05123365 | University of California, Irvine | Myeloproliferative Neoplasm|MPN|Essential Thrombocythemia|Polycythemia Vera|Myelofibrosis | 2022-01-03 | PHASE1|PHASE2 |
| NCT02972398 | Tianjin Anding Hospital | Major Depressive Disorders | 2015-09 | NA |
| NCT06811675 | China Medical University Hospital | Carbon Monoxide Poisoning|Delayed Neurocognitive Sequelae | 2025-03-23 | PHASE4 |
| NCT01131468 | TC Erciyes University | Drug-induced Ototoxicity in Peritoneal Dialysis Patients | 2008-02 | PHASE2 |
| NCT04964843 | Uniformed Services University of the Health Sciences | Alcohol Use Disorder | 2023-04 | PHASE2 |
| NCT03596125 | Nantes University Hospital | Preterm Delivery | 2018-11-05 | PHASE2|PHASE3 |
| NCT02265224 | Zambon SpA | no Condition | 2014-09 | PHASE1 |
| NCT05142735 | Centre for Addiction and Mental Health | Prodromal Schizophrenia | 2023-01-13 | NA |
| NCT03708458 | Grigore T. Popa University of Medicine and Pharmacy | Post-ERCP Pancreatitis | 2017-04-01 | PHASE4 |
| NCT01612221 | University of Utah | Patients at Risk for Melanoma | 2012-09 | PHASE2 |
| NCT04793646 | University of Sao Paulo General Hospital | Sj?gren Syndrome|Sicca Syndrome | 2021-04-30 | NA |
| NCT00896025 | University of Texas Southwestern Medical Center|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Acute Liver Failure|Fulminant Hepatic Failure | 2008-12 | PHASE4 |
| NCT01675661 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Cannabis Dependence | 2014-01 | PHASE3 |
| NCT06311045 | NYU Langone Health|National Heart, Lung, and Blood Institute (NHLBI) | Obstructive Sleep Apnea | 2024-05-07 | NA |
| NCT00539188 | Yale University | Borderline Personality Disorder|Self-Injurious Behavior | 2007-09 | PHASE2 |
| NCT00870883 | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude|Conselho Nacional de Desenvolvimento Científico e Tecnológico | Hypotension|Acute Renal Failure | 2009-03 | PHASE2 |
| NCT00808795 | Tehran University of Medical Sciences | Radiocontrast-Induced Nephropathy|Chronic Kidney Disease|Diabetes Mellitus | 2006-04 | PHASE3 |
| NCT00993265 | Yale University|Trichotillomania Learning Center | Trichotillomania|Hair Pulling | 2009-10 | PHASE2 |
| NCT02141620 | University of Kentucky|National Institute on Drug Abuse (NIDA) | Cocaine Abuse|Cocaine Dependence | 2014-05 | EARLY_PHASE1 |
| NCT01394510 | Utzschneider, Kristina, M.D.|VA Puget Sound Health Care System | Type 2 Diabetes|Oxidative Stress | 2011-06 | NA |
| NCT04374461 | Memorial Sloan Kettering Cancer Center | Covid-19 | 2020-05-01 | PHASE2 |
| NCT06019520 | Foundation University Islamabad | Drug Toxicity | 2023-08-09 | NA |
| NCT05736887 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | COVID-19 | 2022-05-24 | PHASE2 |
| NCT05074121 | Cambridge Health Alliance|The Thoracic Foundation|Alturix | Covid19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Lower Respiratory Infection|SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Oxidative Stress | 2024-03-31 | PHASE2 |
| NCT01808521 | Bloodworks|University of Washington | Purpura, Thrombotic Thrombocytopenic|TTP | 2013-05 | EARLY_PHASE1 |
| NCT00655928 | Imperial College London|Royal College of Physicians|Royal Brompton & Harefield NHS Foundation Trust | Acute Lung Injury | 2007-08 | PHASE2 |
| NCT03149107 | University Hospital, Bonn|University of Cologne|Central Institute of Mental Health, Mannheim|Ludwig-Maximilians - University of Munich|University Hospital Tuebingen|Heinrich-Heine University, Duesseldorf|Charite University, Berlin, Germany|RWTH Aachen University | Prodromal Schizophrenia | 2016-09-01 | PHASE3 |
| NCT03510741 | Pakistan Institute of Living and Learning | Schizophrenia|Schizophreniform Disorders|Schizoaffective Disorder | 2019-01-01 | PHASE2 |
| NCT03221231 | Universitair Ziekenhuis Brussel | Cannabis Use Disorder|Cannabis Dependence | 2016-05-15 | PHASE4 |
| NCT01033149 | Lindner Center of HOPE|University of Cincinnati | Bulimia Nervosa | 2009-12 | PHASE3 |
| NCT00775476 | State University of New York - Upstate Medical University|Cedars-Sinai Medical Center|Penn State University|Columbia University|Hospital for Special Surgery, New York|Yale University|Ohio State University|Oklahoma City VA Health Care System|St. Luke´s Hospital and Health Network, Pennsylvania|Emory University|University of Pittsburgh|University of Kentucky|University of Rochester | Systemic Lupus Erythematosus | 2022-05-05 | PHASE2 |
| NCT02252341 | Universidade Estadual de Maringá | Bipolar Disorder | 2014-09 | PHASE4 |
| NCT04740580 | Baylor College of Medicine|The Methodist Hospital Research Institute | Alzheimer Disease | 2022-02-15 | EARLY_PHASE1 |
| NCT02723162 | Medical University of South Carolina | Nicotine Dependence, Cigarettes | 2016-05-04 | PHASE2 |
| NCT03711838 | University of Thessaly | Satellite Cells|Redox Status|Exercise-induced Muscle Trauma|Aseptic Inflammation | 2019-07-22 | NA |
| NCT00507052 | Assaf-Harofeh Medical Center | Hemodialysis|Renal Failure | | NA |
| NCT05537220 | Johns Hopkins University|National Eye Institute (NEI)|Duke University|Emory University|Massachusetts Eye and Ear Infirmary|Mayo Clinic|Medical College of Wisconsin|Retina Foundation of the Southwest|Stanford University|University of California, Davis|University of Florida|University of Iowa|University of Miami|University of Michigan|University of Minnesota|University of Oklahoma|University of Southern California|University of Utah|University of Washington|University of Wisconsin, Madison|Vanderbilt University|Vitreo Retinal Associates, PA|University of Houston|Medical University of Graz|McGill University|Universit?t Tübingen|Radboud University Medical Center|University of Amsterdam|University Hospital, Basel, Switzerland|University College London Hospitals|Northwestern University|University of Pennsylvania | Retinitis Pigmentosa | 2023-10-11 | PHASE3 |
| NCT00994305 | University of Sao Paulo General Hospital|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Renal Transplantation | 2005-04 | NA |
| NCT01017796 | University of Thessaly | Contrast Induced Nephropathy | 2009-01 | EARLY_PHASE1 |
| NCT00639496 | Zambon SpA | Pulmonary Fibrosis | 2000-03 | PHASE3 |
| NCT03008889 | Emory University | Autism Spectrum Disorder | 2018-07-05 | PHASE2 |
| NCT00122018 | Linda F. Barr, M.D.|Abbott | Kidney Failure, Acute|Kidney Failure, Chronic|Cardiac Surgical Procedures | 2002-05 | PHASE2 |
| NCT04557215 | Cedars-Sinai Medical Center|Bausch Health Ireland Limited | Irritable Bowel Syndrome With Diarrhea | 2020-11-13 | PHASE1|PHASE2 |
| NCT01797575 | The University of Texas Health Science Center, Houston|Stanley Medical Research Institute | Bipolar Disorder | 2013-01 | PHASE2 |
| NCT02966873 | Medical University of South Carolina|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health (NIH) | Post Traumatic Stress Disorder (PTSD)|Addiction|Alcohol Abuse | 2016-10-01 | PHASE2 |
| NCT03164421 | Zagazig University | PCOS | 2017-01 | PHASE2 |
| NCT04278898 | Stanford University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Autism Spectrum Disorder | 2021-02-12 | PHASE2 |
| NCT03556371 | University of Concepcion, Chile|Comisión Nacional de Investigación Científica y Tecnológica | Cocaine-Related Disorders | 2018-04-09 | PHASE2 |
| NCT01891292 | The University of The West Indies|Caribbean Health Research Council | Microalbuminuria|Sickle Cell Nephropathy | 2013-07 | NA |
| NCT06354712 | Mansoura University | Oral Mucositis (Ulcerative) Due to Radiation | 2024-04-04 | PHASE2 |
| NCT01653171 | Pontificia Universidad Catolica de Chile | Stomach Neoplasms | 2012-07 | PHASE4 |
| NCT00434005 | University of Washington|National Institutes of Health (NIH) | Healthy | 2008-07 | NA |
| NCT07245095 | Hospital General de Mexicali | Esophagogastroduodenoscopy|Simethicone|N-Acetylcysteine|Premedication|Visualization|Esophagogastroduodensocopy (EGD) Procedure|Placebo - Control|Gastritis Associated With Helicobacter Pylori|Tumor Gastric|Lesions in the Esophagus, Stomach, Duodenum or Rectum | 2025-09-12 | PHASE2 |
| NCT03652753 | University of Missouri-Columbia | Pilon Fracture | 2019-01-01 | PHASE4 |
| NCT07262554 | Alexandria University | Apical Periodontitis | 2025-11-15 | PHASE2 |
| NCT00467831 | National Human Genome Research Institute (NHGRI) | Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease | 2007-04 | PHASE1|PHASE2 |
| NCT06377410 | National University of Malaysia | Chronic Obstructive Pulmonary Disease | 2024-05-01 | NA |
| NCT00136825 | National Institute on Drug Abuse (NIDA) | Cocaine-Related Disorders | 2003-03 | PHASE1 |
| NCT02094625 | Children´s Hospital Los Angeles | Neuroectodermal Tumors, Primitive|Liver Neoplasms|Osteosarcoma|Other Childhood Cancers Using Cisplatin-based Regimens | 2016-03 | PHASE1 |
| NCT02775734 | Ain Shams University | Clomiphene Citrate Resistant Polycystic Ovary Syndrome | 2016-05 | PHASE2|PHASE3 |
| NCT01800526 | Bloodworks|University of Washington | Sickle Cell Disease|Sickle Cell Anemia | 2013-03 | PHASE1|PHASE2 |
| NCT02686385 | Institute of Liver and Biliary Sciences, India | Drug Induced Liver Injury | 2016-03-01 | NA |
| NCT01699204 | University of British Columbia | Asthma | 2007-09 | NA |
| NCT03581084 | University of California, San Francisco|National Heart, Lung, and Blood Institute (NHLBI) | Asthma | 2018-07-06 | PHASE4 |
| NCT01550432 | Stanford University|National Center for Complementary and Integrative Health (NCCIH) | Obesity|Hyperlipidemia|Insulin Resistance|Hypertension | 2011-06 | NA |
| NCT02088216 | Qilu Hospital of Shandong University | Non-Cystic Fibrosis Bronchiectasis | 2014-04-01 | NA |
| NCT00830193 | Unity Health Toronto|Martin, Claudio M., M.D.|Fran Priestap | Contrast Induced Nephropathy|Critically Ill | 2002-08 | PHASE2|PHASE3 |
| NCT05494398 | Stanford University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Autism Spectrum Disorder | 2024-03-12 | PHASE2|PHASE3 |
| NCT04755972 | Clinical Hospital Center, Split | Corona Virus Infection|Pneumonia, Ventilator-Associated | 2020-10-01 | NA |
| NCT00579995 | University of Nebraska | Nephropathy | 2005-05-01 | NA |
| NCT00585559 | Vanderbilt University Medical Center|National Institutes of Health (NIH)|National Institute of General Medical Sciences (NIGMS) | Aneurysmal Subarachnoid Hemorrhage|Cerebral Vasospasm | 2007-04 | PHASE3 |
| NCT00498342 | University of Vermont|FlowMedic | Chronic Kidney Disease | 2007-06 | NA |
| NCT03911414 | Massachusetts General Hospital | Mood Disturbance|Mood Disorders|Natural Supplements|Alternative Treatment | 2019-06-18 | PHASE4 |
| NCT02249546 | National Taiwan University Hospital | Helicobacter Pylori Infection | 2014-09 | PHASE4 |
| NCT04023266 | University of Alberta | STEMI | 2019-09-20 | PHASE2 |
| NCT04013555 | University of Maryland, Baltimore | Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder | 2020-01-20 | PHASE1|PHASE2 |
| NCT04982146 | Maimónides Biomedical Research Institute of Córdoba | Pseudomyxoma Peritonei | 2021-09-13 | PHASE1 |
| NCT06165068 | Navamindradhiraj University | Dry Age-related Macular Degeneration | 2023-12 | PHASE3 |
| NCT07543458 | Oxford University Clinical Research Unit, Vietnam|University of Oxford|The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam|Number 2 Children´s Hospital, Ho Chi Minh City|Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal|National Academy of Medical Sciences+Bir Hospital, Kathmandu, Nepal|Siriraj Hospital|Prince of Songkla University in Southern Thailand, Thailand|Dhaka Medical College|Chittagong Medical College Hospital, Chittagong, Bangladesh|Centro de Atención y Diagnóstico de Enfermedades Infecciosas, Bucaramanga, Colombia|Hospital Universitario Erasmo Meoz, Cucuta, Colombia|Fundación Valle del Lili, Cali, Colombia|Hospital Regional de Loreto, Iquitos, Peru|Instituto de Infectologia Emílio Ribas, S?o Paulo, Brazil|Universitas Sumatera Utara, Medan, Indonesia|Airlangga University (UNAIR), Indonesia|University Malaya Medical Centre, Malaysia|Hospital Queen Elizabeth II, Malaysia|San Lazaro Hospital (SLH-NU), Manila, Philippines | Dengue|Severe Dengue|Mosquito-Borne Diseases|Vector Borne Diseases|Arbovirus Infections|Flavivirus Infections|RNA Virus Infections|Hemorrhagic Fever | 2026-10-01 | PHASE3 |
| NCT01214083 | VA Office of Research and Development | Alcoholism | 2010-10-15 | PHASE2 |
| NCT03956888 | Siriraj Hospital | Chronic Obstructive Pulmonary Disease | 2019-05-01 | PHASE3 |
| NCT01021163 | Yonsei University | Coronary Artery Occlusion | | PHASE4 |
| NCT01597765 | Mahidol University|Chiang Mai University | Thalassemia | 2009-06 | NA |
| NCT06377631 | Fundació Eurecat|Centre de Diagnosi per la Imatge|Instituto de Investigación Biomédica de Girona (IDIBGI)|Laboratorio de Referencia de Catalu?a | Visceral Obesity|Non-alcoholic Fatty Liver|Postmenopausal | 2024-06-07 | NA |
| NCT02583672 | University of Minnesota|Rare Diseases Clinical Research Network|National Center for Advancing Translational Sciences (NCATS)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institute of Neurological Disorders and Stroke (NINDS)|Lysosomal Disease Network | Gaucher Disease Type 1 | 2015-09 | PHASE2 |
| NCT03557229 | American British Cowdray Medical Center | Oxidative Stress|Septic Shock | 2018-07-23 | PHASE3 |
| NCT02750319 | Memorial Sloan Kettering Cancer Center|Washington University School of Medicine|The Cleveland Clinic|Vanderbilt University School of Medicine | Thoracic Surgery|Atrial Fibrillation in High Risk Patients | 2016-04 | PHASE3 |
| NCT07290530 | Nacuity Pharmaceuticals, Inc. | Retinitis Pigmentosa (RP)|Usher Syndrome | 2026-06 | PHASE3 |
| NCT05994534 | Nacuity Pharmaceuticals, Inc. | Cystinosis | 2023-10-29 | PHASE1|PHASE2 |
| NCT02761577 | Clinical Hospital Centre Zagreb | Kidney Diseases|Contrast Media Reaction | 2012-06 | PHASE4 |
| NCT00568087 | Minneapolis Veterans Affairs Medical Center|Minnesota Veterans Medical Research and Education Foundation | Alcoholism | 2007-12 | PHASE1|PHASE2 |
| NCT04155632 | Medical University of South Carolina|National Institute on Drug Abuse (NIDA) | Cocaine-Related Disorders | 2020-12-18 | PHASE2 |
| NCT01172275 | Yale University | Obsessive-Compulsive Disorder | 2012-07 | PHASE2 |
| NCT02971306 | Post Graduate Institute of Medical Education and Research, Chandigarh | Alcoholic Hepatitis | 2014-07 | PHASE4 |
| NCT01427517 | University of Minnesota|Rare Diseases Clinical Research Network|National Center for Advancing Translational Sciences (NCATS)|National Institute of Neurological Disorders and Stroke (NINDS)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Parkinson´s Disease|Gaucher´s Disease | 2011-07 | PHASE1 |
| NCT01501110 | Federal University of Rio Grande do Sul|Hospital de Clinicas de Porto Alegre|Programa de pós-gradua??o em endocrinologia | Acute Myocardial Infarction|Euthyroid Sick Syndrome|Ischemic Heart Disease | 2011-11 | PHASE4 |
| NCT00196885 | German Cancer Research Center|Heidelberg University | Gastrointestinal Neoplasms|Bronchial Carcinoma|Hodgkin Disease|Non-Hodgkin Lymphoma|Weight Loss | 2003-12 | PHASE2 |
| NCT00506506 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph´s|The Physicians´ Services Incorporated Foundation | Chronic Kidney Disease | 2007-10 | PHASE3 |
| NCT00267384 | Soroka University Medical Center | Drug Induced Nephrotoxicity | 2006-03 | PHASE2|PHASE3 |
| NCT07374991 | University of Gaziantep | COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) | 2020-11-01 | NA |
| NCT00572663 | Medical University of Gdansk | Chronic Kidney Disease|Proteinuria | 2005-01 | NA |
| NCT01232790 | Yale University|National Alliance for Research on Schizophrenia and Depression | Schizophrenia | 2010-02 | NA |
| NCT00453180 | Indiana University|National Alliance for Autism Research | Autistic Disorder|Asperger Syndrome|Child Development Disorders, Pervasive | 2007-03 | PHASE2 |
| NCT07273071 | Theis S. Itenov|University Hospital Bispebjerg and Frederiksberg | Sepsis|Acute Infection|Severe Infection | 2026-07 | PHASE4 |
| NCT05706402 | Queen Mary Hospital, Hong Kong | Chronic Obstructive Pulmonary Disease | 2023-09-18 | PHASE3 |
| NCT00822263 | Brooke Army Medical Center | Mild Traumatic Brain Injury | 2008-11 | NA |
| NCT05903014 | Indonesia University | Nicotine Dependence|Nicotine Addiction | 2023-01-01 | PHASE4 |
| NCT02182167 | University of Cape Town|Medical Research Council, South Africa | Drug-Induced Liver Injury | 2014-05 | PHASE2|PHASE3 |
| NCT01866644 | Instituto de Investigacion Sanitaria La Fe | Unspecified Complication of Liver Transplant | 2011-09 | PHASE3 |
| NCT07464886 | University of Cincinnati|National Center for Complementary and Integrative Health (NCCIH) | Mild Depression | 2026-02-26 | PHASE3 |
| NCT05242718 | Immunoflex Therapeutics Inc.|Dicentra Inc.|University of British Columbia | Immunity Disorders | 2021-01-10 | NA |
| NCT02971878 | Fertilitetscentrum AB|Vitrolife | Culture Media|Blastocyst|Antioxidants|Embryo|Human | 2016-11 | NA |
| NCT02718079 | Institute of Liver and Biliary Sciences, India | Acute Liver Failure | 2016-12-30 | NA |
| NCT01840345 | Virginia Commonwealth University | Neuropathic Pain | 2014-01 | PHASE2 |
| NCT03391856 | Peking University People´s Hospital|The First Affiliated Hospital of Soochow University|Nanfang Hospital, Southern Medical University | Thrombocytopenia|Stem Cell Transplant Complications | 2018-03-01 | PHASE2|PHASE3 |
| NCT03236220 | Peking University People´s Hospital | Haploidentical Hematopoietic Stem Cell Transplantation | 2017-08-01 | PHASE2 |
| NCT03982537 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Head and Neck Cancer | 2020-06-18 | PHASE2 |
| NCT06024031 | Peking University People´s Hospital | Acute Myeloid Leukemia | 2023-09-10 | PHASE2 |
| NCT03967665 | Peking University People´s Hospital | Stem Cell Transplant Complications | 2018-10-01 | PHASE3 |
| NCT01047956 | Taichung Veterans General Hospital | Opioids Use | 2009-06 | PHASE4 |
| NCT07323446 | Massachusetts General Hospital|Massachusetts Institute of Technology | Emotional Dysregulation | 2027-01-01 | EARLY_PHASE1 |
| NCT06417190 | Leslie Ballas | Muscle-Invasive Bladder Carcinoma|Tumor | 2026-01-16 | PHASE2 |
| NCT01241513 | United States Army Research Institute of Environmental Medicine | Effects of High Altitude|Hypoxia|Inadequate or Impaired Breathing Pattern or Ventilation|Abnormal Blood Oxygen Pressure | 2010-11-01 | PHASE4 |
| NCT00501475 | Seoul National University Hospital | Chronic Renal Failure | 2007-03 | PHASE4 |
| NCT05796401 | Centre Hospitalier St Anne | Psychosis | 2023-12-15 | PHASE3 |
| NCT04440280 | Massachusetts Eye and Ear Infirmary | Fuchs Endothelial Corneal Dystrophy | 2020-09-16 | PHASE2 |
| NCT02015403 | Institute of Liver and Biliary Sciences, India | Ischemic Hepatitis | 2013-12 | NA |
| NCT03069300 | Imperial College London | Alcoholic Hepatitis|Infection | 2015-10-01 | PHASE3 |
| NCT02259595 | Otologic Pharmaceutics, Inc. | Hearing Loss|Sensorineural Hearing Loss|Noise-Induced Hearing Loss | 2014-10 | PHASE1 |
| NCT06152653 | University of California, San Francisco|National Heart, Lung, and Blood Institute (NHLBI) | Asthma|COPD | 2024-04-09 | PHASE4 |
| NCT01878344 | Suleyman Demirel University | Acute ST Segment Elevation Myocardial Infarction | 2013-01 | PHASE3 |
| NCT07155044 | Changhai Hospital | UTUC|UC (Urothelial Cancer) | 2024-05-15 | |
| NCT03347474 | Ruijin Hospital | Treatment Methamphetamine Addiction | 2017-09-20 | NA |
| NCT03121989 | Sunnybrook Health Sciences Centre | Breast Cancer | 2017-11-21 | PHASE1 |
| NCT07228325 | Nasus Pharma | Anaphylaxis|Allergy | 2025-11-03 | PHASE1|PHASE2 |
| NCT01957917 | University of California, Berkeley|National Institute of Mental Health (NIMH)|Ministry of Health and Social Welfare, Tanzania | HIV | 2013-12 | NA |
| NCT05485558 | Tanta University | Drug Resistant Epilepsy | 2022-09-15 | PHASE2 |
| NCT02510456 | Boston Medical Center|American Cancer Society, Inc. | Breast Cancer | 2015-01 | |
| NCT00597376 | Rush University Medical Center|Pamlab, Inc. | Subjective Memory Loss in Older Persons | 2007-11 | NA |
| NCT05576428 | Dow University of Health Sciences | NAFLD | 2022-11-01 | NA |
| NCT04677816 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Triple Negative Breast Cancer|Vitamin D Deficiency|Invasive Breast Cancer | 2021-10-22 | PHASE2 |
| NCT05840640 | Post Graduate Institute of Medical Education and Research, Chandigarh | Alcoholic Hepatitis | 2017-10-01 | PHASE4 |
| NCT05509153 | Western Sydney Local Health District|Deakin University|Monash University|Royal Perth Hospital|The University of Queensland|University of Melbourne | Huntington Disease | 2024-06-01 | PHASE2 |
| NCT04594733 | Medical University of South Carolina | Fibromyalgia | 2021-12-06 | PHASE1|PHASE2 |
| NCT06367413 | University of Thessaly | Aseptic Muscle Injury | 2024-04-08 | NA |
| NCT02054949 | Nationwide Children´s Hospital | Autistic Disorder|Seizures|Irritability | 2013-04 | NA |
| NCT04354077 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)|Abbott | Opioid-use Disorder | 2022-02-07 | NA |
| NCT05371288 | University of California, Irvine|Hudson Valley Healing Arts Center | COVID-19 | 2025-06 | EARLY_PHASE1 |
| NCT03238404 | JIANG Zhi-Wei | Gastric Cancer | 2015-08-01 | NA |
| NCT04542161 | Weill Medical College of Cornell University|National Institute of Neurological Disorders and Stroke (NINDS) | Chronic Fatigue Syndrome|Myalgic Encephalomyelitis | 2020-09-01 | PHASE2 |
| NCT06581783 | Asian Institute of Gastroenterology, India | Endoscopy, Digestive System | 2024-12-01 | NA |
| NCT04693949 | University of Ljubljana, Faculty of Medicine | Missing Incisors|Zirconia Surface Pretreatment|Children|Adults|Debonding | 2018-01-03 | NA |
| NCT01612013 | Federal University of S?o Paulo|Hospital das For?as Armadas, Brazil|InCor Heart Institute | Acute Renal Failure | 2005-05 | NA |
| NCT05558358 | University of Colorado, Denver|National Institute on Drug Abuse (NIDA)|University of Nebraska | Methamphetamine Use Disorder | 2024-01-15 | PHASE1|PHASE2 |
| NCT02481609 | University of Miami | Anosmia | 2014-07 | EARLY_PHASE1 |
| NCT00205647 | Wake Forest University|Zambon SpA | Chronic Bronchitis | 1997-01 | PHASE2 |
| NCT01218178 | Catholic University of the Sacred Heart|Policlinico Casilino ASL RMB | Acute Myocardial Infarction|Acute Kidney Injury | 2008-06 | |
| NCT01852825 | Merck Sharp & Dohme LLC|ALK-Abelló A+S | Allergic Rhinitis|Allergic Rhinoconjunctivitis | 2013-11-27 | PHASE1 |
| NCT03063021 | Johns Hopkins University | Retinitis Pigmentosa | 2017-02-15 | PHASE1 |
| NCT00939913 | Ochsner Health System|Cumberland Pharmaceuticals | Nephropathy | 2007-01 | PHASE4 |
| NCT03879759 | South West Sydney Local Health District|National Health and Medical Research Council, Australia|University of Sydney | Alcohol Dependence | 2018-08-22 | PHASE2 |
| NCT06252519 | University of Memphis|Nature Fusions | Pharmacokinetics | 2023-09-18 | NA |
| NCT03999021 | Johns Hopkins University|Zambon SpA | Retinitis Pigmentosa | 2019-06-24 | PHASE1 |
| NCT01896492 | Woman´s Health University Hospital, Egypt | PCOS | 2011-01 | PHASE4 |
| NCT04990609 | The University of Texas Health Science Center, Houston|National Cancer Institute (NCI) | Pancreatic Ductal Adenocarcinoma (PDAC) | 2021-08-13 | PHASE2 |
| NCT06831136 | The University of Texas Health Science Center, Houston | Pancreatic Ductal Adenocarcinoma | 2025-03-26 | PHASE2 |
| NCT00889538 | University of Louisville|Cumberland Pharmaceuticals|Norton Healthcare | Autism|Severe Behavior Disorder | 2009-04 | NA |
| NCT03534115 | University of California, Los Angeles | Removal of Toxicity From Dental Bleaching | 2014-12-04 | EARLY_PHASE1 |
| NCT06909799 | The Aurum Institute NPC|Ludwig-Maximilians - University of Munich|Research Center Borstel | Tuberculosis (TB) | 2025-04-28 | NA |
| NCT03253328 | Washington University School of Medicine | Diabetes Mellitus|Critical Limb Ischemia|Lower Limb Amputation Knee|Peripheral Arterial Disease | 2017-03-01 | EARLY_PHASE1 |
| NCT07301294 | Menoufia University | Double J Stent | 2026-01-01 | PHASE4 |
| NCT03450031 | Fraunhofer-Institute of Toxicology and Experimental Medicine|UCB Pharma | Seasonal Allergic Rhinitis | 2018-02-08 | NA |
| NCT00956748 | St. Paul´s Hospital, Canada | Otitis Media|Otorrhea | 2019-11-29 | PHASE4 |